Home › Studies › PRJNA521587
PRJNA521587 SRP185463

Gut microbiome in fibromyalgia vs healthy controls

Gut microbiome in individuals with fibromyalgia - WGS

A case-control study comparing the gut microbiome of fibromyalgia patients and healthy controls using 16S rRNA and metagenomic sequencing, based on 156 samples (mostly adults); country not reported. machine-written summary

156 samples · 156 runs · CA · Adult · 2019 · 2.43 Gbp / sample

Sources
✓Sequence archive 810–Abstract / description–Full text–Supplementary tables✓External resources 156–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive810 sample values (age, family role, health condition, health condition detail, sex, shared setting type, subject id)
– Abstract / descriptionno abstract or project description
– Full textno open-access full text linked
– Supplementary tablesno supplementary tables available (or none open access)
✓ External resources156 sample values (country) · from GMrepo v3
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Samples at a glance
1 country
Age
adult150
elderly5
infant1
Condition
healthy_control79
other_disease77
Sex
female156
Country
CA156
Body site
primary156
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)this project, 0.1–0.3 Gbp: 1 samplesall projects, 0.3–1 Gbp: 47,044 samples (8 %)this project, 0.3–1 Gbp: 1 samplesall projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 143 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 11 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)all projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 2.43 Gbp per sample0130Gbp
Sampling design and relatedness

families — not resolvedhouseholds — not resolved

Fibromyalgia study: 11 first-degree relatives and 20 same-household controls of patients; index patient not identified per control.

How longitudinal and relatedness information is derived

Community composition
Bacteroides 15.4%Phocaeicola 11.7%Alistipes 6.8%Prevotella 5.6%Roseburia 4.2%Faecalibacterium 3.3%Parabacteroides 1.9%Lachnospira 1.8%Vescimonas 1.4%Gemmiger 1.3%Acetatifactor 1.3%Ruminococcoides 1.1%not assigned to a genus 7.4%other genera 37.0%

Genera, mean relative abundance over 145 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category156 100%
country156 100%156
health_condition156 100%156
subject_id156 100%156
health_condition_detail156 100%156
sex156 100%156
age_at_collection_days155 99%155
shared_setting_type20 13%20
family_role11 7%11
Details
Archive description

A cross-sectional comparative study aiming to characterise the gut microbiome of fibromyalgia (FM) patients as compared to healthy controls. Fecal samples were analysed using 16S rRNA and metagenomic sequencing.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of adult by deterministic_prior with confidence 0.90. Assay shotgun_dna.

  • host external_curation.infant_catalog · “infant triage reason_code age_adult_only”
  • body site study.title · “Gut microbiome in individuals”
  • body site study.description · “to characterise the gut microbiome of fibromyalgia”
  • life stage external_curation.infant_catalog · “infant triage reason_code age_adult_only”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN10886000age_at_collection_days18993.0R10.70sample.attr.age52
SAMN10886036age_at_collection_days43464.8R10.85biosample.attribute:age119
SAMN10886000countryCAR20.75external.gmrepo sourcecountry: Canada
SAMN10886027family_roleother_relativeR10.85biosample.attribute:diseaseFirst-degree relation with a patient (Control Group)
SAMN10886000health_conditionother_diseaseR10.70biosample_attrPatient with Fibromylagia (FM Group)
SAMN10886000health_condition_detailPatient with Fibromylagia (FM Group)R10.90sample.attr.diseasePatient with Fibromylagia (FM Group)
SAMN10886000sexfemaleR10.90sample.attr.sexfemale
SAMN10886006shared_setting_typehouseholdR10.85biosample.attribute:diseaseSame Household adress as Patient (Control Group)
SAMN10886000subject_idPt_Fibro_122R10.85biosample.attribute:isolatePt_Fibro_122
Sequencing

156 runs over 156 samples · mean 2.48 Gbp per run (median 2.43 Gbp, total 386.96 Gbp; 156 runs with a base count) · layout PAIRED 156 · platform ILLUMINA 156 · models Illumina HiSeq 4000 (156) · 93% of runs with a Sandpiper profile · first public 2019-11-28

Authors (24)

Argentini C first · Lugli GA · Tarracchini C · Fontana F · Mancabelli L · Viappiani A · Anzalone R · Angelini L · Alessandri G · Longhi G · Bianchi MG · Taurino G · Bussolati O · Milani C · van Sinderen D · Turroni F · Ventura M last · De Biase R · Bocchio F · De Conto F · Nouvenne A · Ticinesi A · Meschi T · Cecchi R

Downloads

PRJNA521587.csv.gz (5.4 KB) · parquet (77.7 KB) — all 156 samples, every field with route and confidence · PRJNA521587_determinations.csv.gz (8.6 KB) — 966 evidence rows

Samples (156 · every field this project has values for · hover a cell for its source)
Loading the sample table…